Ttr has been demonstrated to reduce Aβ‐induced toxicity in hippocampal neurons and in mouse models of Alzheimer's disease (Alemi et al. 2017; Silva et al. 2017). This evidence concerns the gene TTR and early-onset autosomal dominant Alzheimer disease.